Healthcare provider profile · identity verified

Peter Robert Ansorge, MD

Family Practice · LAFAYETTE, IN · NPI 1346445277

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	895	241
Lisinopril	Lisinopril	501	135
Levothyroxine Sodium	Levothyroxine Sodium	500	107
Metformin Hcl	Metformin Hcl	443	115
Amlodipine Besylate	Amlodipine Besylate	387	113
Omeprazole	Omeprazole	372	87
Gabapentin	Gabapentin	310	71
Albuterol Sulfate Hfa	Albuterol Sulfate	223	68
Tamsulosin Hcl	Tamsulosin Hcl	213	60
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	205	50
Hydrochlorothiazide	Hydrochlorothiazide	202	57
Pantoprazole Sodium	Pantoprazole Sodium	201	52
Losartan Potassium	Losartan Potassium	182	55
Sertraline Hcl	Sertraline Hcl	171	39
Furosemide	Furosemide	169	46
Jardiance	Empagliflozin	169	41
Metoprolol Tartrate	Metoprolol Tartrate	169	38
Mounjaro	Tirzepatide	168	31
Metoprolol Succinate	Metoprolol Succinate	165	47
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	153	38
Potassium Chloride	Potassium Chloride	147	43
Simvastatin	Simvastatin	133	34
Allopurinol	Allopurinol	121	34
Ozempic	Semaglutide	120	28
Pravastatin Sodium	Pravastatin Sodium	117	31
Eliquis	Apixaban	115	21
Valsartan	Valsartan	115	34
Baclofen	Baclofen	109	25
Trazodone Hcl	Trazodone Hcl	101	30
Rosuvastatin Calcium	Rosuvastatin Calcium	99	32
Meloxicam	Meloxicam	86	29
Montelukast Sodium	Montelukast Sodium	83	23
Januvia	Sitagliptin Phosphate	78	16
Alprazolam	Alprazolam	77	14
Paroxetine Hcl	Paroxetine Hcl	77	16
Fluticasone Propionate	Fluticasone Propionate	70	25
Glimepiride	Glimepiride	69	20
Duloxetine Hcl	Duloxetine Hcl	67	20
Fluoxetine Hcl	Fluoxetine Hcl	67	22
Bupropion Xl	Bupropion Hcl	63	17
Tizanidine Hcl	Tizanidine Hcl	62	16
Atenolol	Atenolol	61	18
Carvedilol	Carvedilol	60	17
Hydroxyzine Hcl	Hydroxyzine Hcl	58	16
Buspirone Hcl	Buspirone Hcl	57	13
Metformin Hcl Er	Metformin Hcl	57	14
Tramadol Hcl	Tramadol Hcl	57	suppressed
Celecoxib	Celecoxib	56	14
Clopidogrel	Clopidogrel Bisulfate	56	18
Escitalopram Oxalate	Escitalopram Oxalate	56	16
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	56	23
Pregabalin	Pregabalin	52	13
Zolpidem Tartrate	Zolpidem Tartrate	52	12
Esomeprazole Magnesium	Esomeprazole Magnesium	49	12
Propranolol Hcl	Propranolol Hcl	49	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	48	suppressed
Synthroid	Levothyroxine Sodium	48	suppressed
Topiramate	Topiramate	48	suppressed
Spironolactone	Spironolactone	47	16
Oxybutynin Chloride Er	Oxybutynin Chloride	46	11
Diclofenac Sodium	Diclofenac Sodium	45	15
Venlafaxine Hcl Er	Venlafaxine Hcl	44	suppressed
Xarelto	Rivaroxaban	42	11
Amitriptyline Hcl	Amitriptyline Hcl	39	suppressed
Citalopram Hbr	Citalopram Hydrobromide	39	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	39	14
Enalapril Maleate	Enalapril Maleate	38	11
Etodolac	Etodolac	38	14
Ropinirole Hcl	Ropinirole Hcl	38	suppressed
Donepezil Hcl	Donepezil Hcl	35	12
Lovastatin	Lovastatin	35	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	35	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	34	suppressed
Mirtazapine	Mirtazapine	33	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	32	12
Propranolol Hcl Er	Propranolol Hcl	32	suppressed
Bupropion Hcl Sr	Bupropion Hcl	31	suppressed
Valacyclovir	Valacyclovir Hcl	31	14
Wixela Inhub	Fluticasone Propion/Salmeterol	31	suppressed
Benazepril Hcl	Benazepril Hcl	29	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	29	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	29	19
Azithromycin	Azithromycin	28	28
Doxycycline Hyclate	Doxycycline Hyclate	28	12
Irbesartan	Irbesartan	28	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	28	suppressed
Alendronate Sodium	Alendronate Sodium	27	suppressed
Klor-Con M20	Potassium Chloride	27	suppressed
Prednisone	Prednisone	27	24
Hydralazine Hcl	Hydralazine Hcl	25	suppressed
Famotidine	Famotidine	24	suppressed
Risperidone	Risperidone	24	suppressed
Clonidine Hcl	Clonidine Hcl	23	suppressed
Finasteride	Finasteride	22	suppressed
Symbicort	Budesonide/Formoterol Fumarate	22	suppressed
Tradjenta	Linagliptin	22	suppressed
Varenicline Tartrate	Varenicline Tartrate	22	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	21	suppressed
Meclizine Hcl	Meclizine Hcl	21	suppressed
Trintellix	Vortioxetine Hydrobromide	21	suppressed
Linzess	Linaclotide	20	suppressed
Rizatriptan	Rizatriptan Benzoate	19	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	19	18
Aripiprazole	Aripiprazole	18	suppressed
Cephalexin	Cephalexin	18	17
Lamotrigine	Lamotrigine	18	suppressed
Memantine Hcl	Memantine Hcl	18	suppressed
Ramipril	Ramipril	18	suppressed
Trulicity	Dulaglutide	18	suppressed
Dexmethylphenidate Hcl Er	Dexmethylphenidate Hcl	17	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	17	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	17	16
Gemfibrozil	Gemfibrozil	17	suppressed
Naproxen	Naproxen	17	suppressed
Novolog Flexpen	Insulin Aspart	17	suppressed
Divalproex Sodium	Divalproex Sodium	16	suppressed
Ibuprofen	Ibuprofen	16	suppressed
Ventolin Hfa	Albuterol Sulfate	16	suppressed
Bumetanide	Bumetanide	15	suppressed
Glipizide	Glipizide	15	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	15	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	15	suppressed
Solifenacin Succinate	Solifenacin Succinate	15	suppressed
Tiotropium Bromide	Tiotropium Bromide	15	suppressed
Torsemide	Torsemide	15	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	14	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	14	suppressed
Cimetidine	Cimetidine	14	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	14	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	14	suppressed
Methocarbamol	Methocarbamol	14	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	14	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	14	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	14	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	12	suppressed
Calcitriol	Calcitriol	12	suppressed
Clonazepam	Clonazepam	12	suppressed
Diazepam	Diazepam	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Dutasteride	Dutasteride	12	suppressed
Estradiol	Estradiol	12	suppressed
Humalog Kwikpen U-100	Insulin Lispro	12	suppressed
Lorazepam	Lorazepam	12	suppressed
Nystatin	Nystatin	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Vascepa	Icosapent Ethyl	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Breo Ellipta	Fluticasone/Vilanterol	11	suppressed
Carbamazepine	Carbamazepine	11	suppressed
Fluconazole	Fluconazole	11	11
Indapamide	Indapamide	11	suppressed
Invokana	Canagliflozin	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed
Spiriva Handihaler	Tiotropium Bromide	11	suppressed
Sucralfate	Sucralfate	11	suppressed
Warfarin Sodium	Warfarin Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error